Targeting Hv1 proton channels: an innovative therapy for B cell lymphoma

• Unité de recherche: INNOSUISSE
• Numéro de projet: 26125.1 PFLS-LS

Description succincte (Allemand)

Targeting Hv1 proton channels: an innovative therapy for B cell lymphoma

Résumé des résultats (Abstract) (Allemand)

The project aims at providing proof of concept studies for small molecules Hv1 inhibitors developed by HPlus Therapeutics for the treatment of B-cell malignancies. Hv1 promotes tumor growth and can thus be considered as a novel therapeutic target for unmet medical needs.